300181SZSE

Legal Opinion from Shanghai Dongfang Huayin Law Firm on the First Extraordinary Shareholders' Meeting of Zhejiang Zuoli Pharmaceutical Co., Ltd. in 2026

Zhejiang Jolly Pharmaceutical Co., Ltd.·April 30, 2026

✨ AI Summary

This legal opinion confirms the compliance of Zhejiang Zuoli Pharmaceutical Co., Ltd.'s first extraordinary shareholders' meeting in 2026 with relevant laws and regulations. The meeting, held on April 30, 2026, had 487 shareholders representing 198,515,075 shares, accounting for 28.92% of the total voting shares. Key resolutions included the approval of the proposal to conclude certain fundraising projects and permanently supplement working capital with surplus funds.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Shanghai Dongfang Huayin Law Firm
Legal Opinion on the First Extraordinary Shareholders' Meeting of Zhejiang Zuoli Pharmaceutical Co., Ltd. in 2026

To: Zhejiang Zuoli Pharmaceutical Co., Ltd.

Shanghai Dongfang Huayin Law Firm (hereinafter referred to as "this Firm") has been entrusted by Zhejiang Zuoli Pharmaceutical Co., Ltd. (hereinafter referred to as "your company" or "the company") to issue this legal opinion regarding the convening of your company's first extraordinary shareholders' meeting in 2026. This opinion is based on the "Company Law of the People's Republic of China" (hereinafter referred to as "the Company Law"), the "Rules for Shareholders' Meetings of Listed Companies" (hereinafter referred to as "the Shareholders' Meeting Rules"), and other relevant laws, regulations, and normative documents, as well as the "Articles of Association of Zhejiang Zuoli Pharmaceutical Co., Ltd." (hereinafter referred to as "the Articles of Association").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.